Clinical Trial Update: Comparison of Alogliptin Versus Alogliptin and Pioglitazone on Insulin Resistance of Metformin Treated Women With PCOS [Phase 4]

View source ↗

Summary

This Phase 4 trial compares alogliptin alone to alogliptin with pioglitazone in metformin-treated women with polycystic ovary syndrome and insulin resistance; t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insulin Resistance
• Polycystic Ovary Syndrome

Drugs mentioned

• Actos (Pioglitazone)
• Nesina (alogliptin)

Snippet

Sponsor: University Medical Centre Ljubljana | Conditions: Polycystic Ovary Syndrome, Insulin Resistance | Phase 4 | Status: COMPLETED